Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Clinical trial NCT00884182 · COMPLETED

Trial details

NCT number: NCT00884182
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviridae Infections Orthomyxovirus Infections

Start date: 2009-04-01
Primary completion: 2010-03-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.